Pronađeno: 1-5 / 5 radova

Autori: Haslemo Tore

>> Filter: Samo Article i Review

Naslov A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram (Article)
Autori Braten Line Skute  Haslemo Tore  Jukic Marin M  Ivanov Maxim  Ingelman-Sundberg Magnus  Molden Espen  Kringen Marianne Kristiansen 
Info CLINICAL PHARMACOLOGY & THERAPEUTICS, (2021), vol. 110 br. 3, str. 786-793
Projekat South-Eastern Norway Regional Health Authority; Diakonhjemmet Hospital found for research, innovation, and professional development; European Commission [668353]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients (Article)
Autori Braten Line Skute  Haslemo Tore  Jukic Marin M  Ingelman-Sundberg Magnus  Molden Espen  Kringen Marianne Kristiansen 
Info NEUROPSYCHOPHARMACOLOGY, (2020), vol. 45 br. 3, str. 570-576
Projekat South-Eastern Norway Regional Health Authority
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study (Article)
Autori Jukic Marin M  Smith Robert Lovsletten  Haslemo Tore  Molden Espen  Ingelman-Sundberg Magnus 
Info LANCET PSYCHIATRY, (2019), vol. 6 br. 5, str. 418-426
Projekat Swedish Research Council [2015-02760]; European Union's Horizon 2020 research and innovation program U-PGx [668353]; Swedish Brain foundation [FO2017-0111]; South-Eastern Norway Regional Health Authority [2016-097]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients (Article)
Autori Haslemo Tore  Eliasson Erik  Jukic Marin M  Ingelman-Sundberg Magnus  Molden Espen 
Info BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, (2019), vol. 85 br. 1, str. 194-201
Projekat Swedish Research Council [2016-01153, 2015-02760, 2016-01154]; The European Union's Horizon 2020 research and innovation program U-PGx [668353]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients (Article)
Autori Jukic Marin M  Haslemo Tore  Molden Espen  Ingelman-Sundberg Magnus 
Info AMERICAN JOURNAL OF PSYCHIATRY, (2018), vol. 175 br. 5, str. 463-470
Projekat Swedish Research Council [2015-02760]; European Union [668353]; Swedish Brain foundation [FO2015-0235]; South-Eastern Norway Regional Health Authority [2016-097]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX